98 related articles for article (PubMed ID: 10873638)
21. Effect of PD 098059, a specific inhibitor of mitogen-activated protein kinase kinase, on urokinase expression and in vitro invasion.
Simon C; Juarez J; Nicolson GL; Boyd D
Cancer Res; 1996 Dec; 56(23):5369-74. PubMed ID: 8968087
[TBL] [Abstract][Full Text] [Related]
22. Transforming growth factor-beta 1 stimulates macrophage urokinase expression and release of matrix-bound basic fibroblast growth factor.
Falcone DJ; McCaffrey TA; Haimovitz-Friedman A; Garcia M
J Cell Physiol; 1993 Jun; 155(3):595-605. PubMed ID: 7684044
[TBL] [Abstract][Full Text] [Related]
23. Transforming growth factor-beta differently regulates urokinase type plasminogen activator and matrix metalloproteinase-9 expression in mouse macrophages; analysis of intracellular signal transduction.
Mojsilović SS; Santibanez JF
Cell Biol Int; 2015 May; 39(5):619-28. PubMed ID: 25597879
[TBL] [Abstract][Full Text] [Related]
24. Regulation of hepatocyte growth factor-mediated urokinase plasminogen activator secretion by MEK/ERK activation in human stomach cancer cell lines.
Lee KH; Choi EY; Kim MK; Hyun MS; Jang BI; Kim TN; Kim SW; Song SK; Kim JH; Kim JR
Exp Mol Med; 2006 Feb; 38(1):27-35. PubMed ID: 16520550
[TBL] [Abstract][Full Text] [Related]
25. 1alpha,25-dihydroxyvitamin D3 stimulates activator protein 1 DNA-binding activity by a phosphatidylinositol 3-kinase/Ras/MEK/extracellular signal regulated kinase 1/2 and c-Jun N-terminal kinase 1-dependent increase in c-Fos, Fra1, and c-Jun expression in human keratinocytes.
Johansen C; Kragballe K; Henningsen J; Westergaard M; Kristiansen K; Iversen L
J Invest Dermatol; 2003 Apr; 120(4):561-70. PubMed ID: 12648218
[TBL] [Abstract][Full Text] [Related]
26. Requirement of TGF-beta receptor-dependent activation of c-Jun N-terminal kinases (JNKs)/stress-activated protein kinases (Sapks) for TGF-beta up-regulation of the urokinase-type plasminogen activator receptor.
Yue J; Sun B; Liu G; Mulder KM
J Cell Physiol; 2004 May; 199(2):284-92. PubMed ID: 15040011
[TBL] [Abstract][Full Text] [Related]
27. Transforming growth factor-beta1-dependent activation of Smad2/3 and up-regulation of PAI-1 expression is negatively regulated by Src in SKOV-3 human ovarian cancer cells.
Wakahara K; Kobayashi H; Yagyu T; Matsuzaki H; Kondo T; Kurita N; Sekino H; Inagaki K; Suzuki M; Kanayama N; Terao T
J Cell Biochem; 2004 Oct; 93(3):437-53. PubMed ID: 15372629
[TBL] [Abstract][Full Text] [Related]
28. cAMP inhibits the proliferation of retinal pigmented epithelial cells through the inhibition of ERK1/2 in a PKA-independent manner.
Hecquet C; Lefevre G; Valtink M; Engelmann K; Mascarelli F
Oncogene; 2002 Sep; 21(39):6101-12. PubMed ID: 12203122
[TBL] [Abstract][Full Text] [Related]
29. Ras- and mitogen-activated protein kinase kinase-dependent and -independent pathways in p21Cip1/Waf1 induction by fibroblast growth factor-2, platelet-derived growth factor, and transforming growth factor-beta1.
Kivinen L; Laiho M
Cell Growth Differ; 1999 Sep; 10(9):621-8. PubMed ID: 10511312
[TBL] [Abstract][Full Text] [Related]
30. Involvement of protein kinase C-dependent mitogen-activated protein kinase p44/42 signaling pathway for cross-talk between estradiol and transforming growth factor-beta3 in increasing basic fibroblast growth factor in folliculostellate cells.
Chaturvedi K; Sarkar DK
Endocrinology; 2004 Feb; 145(2):706-15. PubMed ID: 14605008
[TBL] [Abstract][Full Text] [Related]
31. Mitogenic conversion of transforming growth factor-beta1 effect by oncogenic Ha-Ras-induced activation of the mitogen-activated protein kinase signaling pathway in human prostate cancer.
Park BJ; Park JI; Byun DS; Park JH; Chi SG
Cancer Res; 2000 Jun; 60(11):3031-8. PubMed ID: 10850453
[TBL] [Abstract][Full Text] [Related]
32. Elevated urokinase-type plasminogen activator receptor expression in a colon cancer cell line is due to a constitutively activated extracellular signal-regulated kinase-1-dependent signaling cascade.
Lengyel E; Wang H; Gum R; Simon C; Wang Y; Boyd D
Oncogene; 1997 May; 14(21):2563-73. PubMed ID: 9191056
[TBL] [Abstract][Full Text] [Related]
33. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells.
Allan EH; Zeheb R; Gelehrter TD; Heaton JH; Fukumoto S; Yee JA; Martin TJ
J Cell Physiol; 1991 Oct; 149(1):34-43. PubMed ID: 1834680
[TBL] [Abstract][Full Text] [Related]
34. Transforming growth factor-beta1-dependent urokinase up-regulation and promotion of invasion are involved in Src-MAPK-dependent signaling in human ovarian cancer cells.
Tanaka Y; Kobayashi H; Suzuki M; Kanayama N; Terao T
J Biol Chem; 2004 Mar; 279(10):8567-76. PubMed ID: 14676209
[TBL] [Abstract][Full Text] [Related]
35. Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent.
Samarakoon R; Higgins CE; Higgins SP; Kutz SM; Higgins PJ
J Cell Physiol; 2005 Jul; 204(1):236-46. PubMed ID: 15622520
[TBL] [Abstract][Full Text] [Related]
36. Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation.
Ellenrieder V; Hendler SF; Boeck W; Seufferlein T; Menke A; Ruhland C; Adler G; Gress TM
Cancer Res; 2001 May; 61(10):4222-8. PubMed ID: 11358848
[TBL] [Abstract][Full Text] [Related]
37. Rac1 modulates TGF-beta1-mediated epithelial cell plasticity and MMP9 production in transformed keratinocytes.
Santibáñez JF; Kocić J; Fabra A; Cano A; Quintanilla M
FEBS Lett; 2010 Jun; 584(11):2305-10. PubMed ID: 20353788
[TBL] [Abstract][Full Text] [Related]
38. Stimulation of Smad1 transcriptional activity by Ras-extracellular signal-regulated kinase pathway: a possible mechanism for collagen-dependent osteoblastic differentiation.
Suzawa M; Tamura Y; Fukumoto S; Miyazono K; Fujita T; Kato S; Takeuchi Y
J Bone Miner Res; 2002 Feb; 17(2):240-8. PubMed ID: 11811554
[TBL] [Abstract][Full Text] [Related]
39. Transforming growth factor β and Ras/MEK/ERK signaling regulate the expression level of a novel tumor suppressor Lefty.
Miyata N; Azuma T; Hozawa S; Higuchi H; Yokoyama A; Kabashima A; Igarashi T; Saeki K; Hibi T
Pancreas; 2012 Jul; 41(5):745-52. PubMed ID: 22441145
[TBL] [Abstract][Full Text] [Related]
40. Breast cancer cells with inhibition of p38alpha have decreased MMP-9 activity and exhibit decreased bone metastasis in mice.
Suarez-Cuervo C; Merrell MA; Watson L; Harris KW; Rosenthal EL; Väänänen HK; Selander KS
Clin Exp Metastasis; 2004; 21(6):525-33. PubMed ID: 15679050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
